1-(2-chloropyridin-4-yl)-3-(pyridin-2-yl)urea

ID: ALA4292870

PubChem CID: 134114171

Max Phase: Preclinical

Molecular Formula: C11H9ClN4O

Molecular Weight: 248.67

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccnc(Cl)c1)Nc1ccccn1

Standard InChI:  InChI=1S/C11H9ClN4O/c12-9-7-8(4-6-13-9)15-11(17)16-10-3-1-2-5-14-10/h1-7H,(H2,13,14,15,16,17)

Standard InChI Key:  VPYIBVZWTOMGGV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.9260   -3.5040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9249   -4.3235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6329   -4.7325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3426   -4.3230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3397   -3.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6311   -3.0951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6287   -2.2779    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.0509   -4.7305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7580   -4.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4663   -4.7283    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7567   -3.5036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1734   -4.3186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8804   -4.7274    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5870   -4.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5862   -3.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8729   -3.0930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1692   -3.5044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4292870

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 248.67

Molecular Weight (Monoisotopic): 248.0465

AlogP: 2.77

#Rotatable Bonds: 2

Polar Surface Area: 66.91

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.84

CX Basic pKa: 3.84

CX LogP: 2.10

CX LogD: 2.10

Aromatic Rings: 2

Heavy Atoms: 17

QED Weighted: 0.80

Np Likeness Score: -2.13

References

1. Papillon JPN, Nakajima K, Adair CD, Hempel J, Jouk AO, Karki RG, Mathieu S, Möbitz H, Ntaganda R, Smith T, Visser M, Hill SE, Hurtado FK, Chenail G, Bhang HC, Bric A, Xiang K, Bushold G, Gilbert T, Vattay A, Dooley J, Costa EA, Park I, Li A, Farley D, Lounkine E, Yue QK, Xie X, Zhu X, Kulathila R, King D, Hu T, Vulic K, Cantwell J, Luu C, Jagani Z..  (2018)  Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.,  61  (22): [PMID:30339381] [10.1021/acs.jmedchem.8b01318]

Source

Source(1):

• Scientific Literature